3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
36
Leukemia
26
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Gastrointestinal Stromal Tumors
13
Leukemia, Myeloid, Chronic-Phase
12
Leukemia, Myeloid
6
Brain Neoplasms
6
Prostatic Neoplasms
5
Philadelphia Chromosome
5
Blast Crisis
5
Sarcoma
4
Recurrence
4
Glioblastoma
4
Carcinoma, Non-Small-Cell Lung
4
Bone Marrow Diseases
4
Ovarian Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Hematologic Diseases
3
Bronchiolitis Obliterans Syndrome
3
Breast Neoplasms
3
Stomach Neoplasms
2
Polycythemia Vera
2
Neurofibromatoses
2
Neoplasms by Histologic Type
2
Neoplasms
2
Neoplasm Metastasis
2
Myeloproliferative Disorders
2
Meningioma
2
Interventions
Radiotherapy, Conformal
2
Ifosfamide
2
Doxorubicin
2
romidepsin
1
indolepropanol phosphate
1
etoposide phosphate
1
Watchful Waiting
1
Vincristine
1
Sunitinib
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Polymerase Chain Reaction
1
Observation
1
Neoadjuvant Therapy
1
Irinotecan
1
HhAntag691
1
Granulocyte Colony-Stimulating Factor
1
Gene Expression Profiling
1
Filgrastim
1
Etoposide
1
Dactinomycin
1
Cyclophosphamide
1
Blotting, Western
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Malignant mesenchymal tumor
×
Imatinib Mesylate
×
Clear all
No trials found.